Skip to content

Influence of Early Wound Healing on the Outcomes of Regenerative Periodontal Surgery

Influence of Early Wound Healing on the 12-month Clinical and Radiographic Outcomes of Regenerative Periodontal Surgery: a Prospective Observational Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07683962
Acronym
EWH_reg
Enrollment
100
Registered
2026-07-06
Start date
2026-07-01
Completion date
2027-10-01
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrabony Periodontal Defect, Wound Healing

Keywords

periodontal regeneration, early wound healing

Brief summary

This study investigates whether early post-surgical healing (1-2 weeks) affects the 12-month clinical and radiographic success of periodontal regenerative therapy, and identifies patient-related, site-specific, and technique-related factors associated with optimal early wound healing, in patients with Stage III-IV periodontitis.

Detailed description

This single-center, prospective observational cohort study addresses two pre-specified aims: (1) the association between early wound healing at 1 and 2 weeks and 12-month clinical and radiographic outcomes; and (2) the identification of patient-related, site-related (e.g., intrabony defect depth, CEJ-to-bone-crest distance, defect configuration, intrabony defect classification), and technique-related (flap design, biomaterial) factors associated with optimal early wound healing.

Interventions

PROCEDUREPeriodontal Regenerative Therapy

All subjects undergo surgical debridement of the intrabony defect followed by a regenerative approach (biologics with or without bone grafts, or blood clot alone) using papilla preservation techniques (MIST, M-MIST, MPPT, SPPF, or SFA).

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Stage III or IV Periodontitis. * Presence of at least one deep interproximal infrabony defect (Probing Pocket Depth \[PPD\] \>= 6 mm, radiographic depth \>= 3 mm). * Optimal oral hygiene: Full-Mouth Plaque Score (FMPS) and Full-Mouth Bleeding Score (FMBS) \< 15% at the time of surgery.

Exclusion criteria

* Systemic: ASA III-VI classification; uncontrolled diabetes; medications causing gingival overgrowth (e.g., nifedipine, cyclosporine, phenytoin); heavy smokers (\>10 cigarettes/day); pregnancy or lactation. * Local: Third molars; Grade III tooth mobility; inadequate endodontic treatment; teeth undergoing orthodontic treatment; teeth supporting removable or implant-linked fixed prosthetics.

Design outcomes

Primary

MeasureTime frame
Change in Clinical Attachment Level (CAL).Baseline and 12 months.

Secondary

MeasureTime frameDescription
Composite healing index (CHI)1 and 2 weeksCHI has two independent, dichotomous domains (wound closure and wound quality), each answering a single clinically distinct question, and reports the outcome as a two-digit composite code.
Probing Pocket Depth (PPD) Change:Baseline and 12 months.
Early Wound Healing Index (EHI)1 and 2 weeksAssessed using the Early Wound Healing Index (EHI). The index ranges from a minimum score of 1 (complete tissue closure without fibrin) to a maximum score of 5 (incomplete tissue closure with partial/complete necrosis). Higher scores mean a worse clinical outcome.
Change in Radiographic ParametersBaseline and 12 months.Measured in millimeters (mm) or degrees (°) on standardized radiographs from baseline to 12 months. It calculates the distance from a fixed reference point (e.g., cementoenamel junction) to the bottom of the bony defect. A positive change (increase in mm) indicates bone gain (better outcome).
Number of analgesic tablets1 and 2 weeks
Percentage of Sites With Bleeding on Probing (BOP)Baseline and 12 monthsPresence or absence of bleeding assessed within 30 seconds of probing at specific sites. The data will be aggregated and reported as the percentage of sites showing bleeding out of the total sites examined. Higher percentages indicate worse outcomes.
Composite outcome measure (COM)12 monthsProportion of sites achieving a combination of PPD ≤ 4 mm and CAL gain ≥ 3 mm
Pocket closure12 monthsProportion of sites achieving a combination of PPD ≤ 4 mm and absence of bleeding on probing

Countries

Italy

Contacts

CONTACTAndrea Pilloni
andrea.pilloni@uniroma1.it+39 3356409374

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026